Abiopharma

🔍 Liuzza Nicholas Reyland JR (Director)

Company: Beeline Holdings, Inc. (BLNE)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 333,333 shares of Common Stock at $1.5 per share (Direct)
  Date: 2026-08-19 | Code: C | equity_swap_involved: 0 | shares_owned_after: 4,527,599.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 256,809.00 | Footnotes: F2
• Acquired 333,333 shares of Convertible Note at $1.5 per share (Derivative)
  Date: 2026-08-19 | Code: C | Expires: 2026-08-19 | Exercise: 2026-08-12 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: The convertible note automatically converted into shares of the Issuer's common stock. The shares of the Issuer's common stock issuable upon conversion of the convertible note are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as the convertible note and the issuance of the underlying common stock was approved in advance by the Issuer's Board of Directors.
• F2: The Reporting Person is trustee of the trust, and members of the Reporting Person's immediate family are beneficiaries of the trust.